Interferon alfa-2b and cytarabine in chronic myelogenous leukemia.
作者信息
Patel T, Roychowdhury D F
出版信息
N Engl J Med. 1997 Nov 27;337(22):1634-5. doi: 10.1056/NEJM199711273372217.
PMID:9411231
Abstract
摘要
相似文献
1
Interferon alfa-2b and cytarabine in chronic myelogenous leukemia.
N Engl J Med. 1997 Nov 27;337(22):1634-5. doi: 10.1056/NEJM199711273372217.
2
Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group.
N Engl J Med. 1997 Jul 24;337(4):223-9. doi: 10.1056/NEJM199707243370402.
3
Optimizing treatment for chronic myeloid leukemia.
N Engl J Med. 1997 Jul 24;337(4):270-1. doi: 10.1056/NEJM199707243370410.
4
Evolving approaches with interferon alfa in chronic myelogenous leukemia.
Semin Hematol. 1993 Jul;30(3 Suppl 3):26-7.
5
Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013.
J Clin Oncol. 2000 Mar;18(6):1301-8. doi: 10.1200/JCO.2000.18.6.1301.
6
Interferon-alpha and cytosine arabinoside therapy in chronic myeloid leukemia.
Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:279-84.
7
Interferon-alpha combined with cytarabine in chronic myelogenous leukemia - clinical benefits.
Leuk Lymphoma. 2001 May;41(5-6):523-33. doi: 10.3109/10428190109060343.
8
Results of a phase II trial testing interferon-alpha 2b and cytarabine in children and adolescents with chronic myelogenous leukemia.
Pediatr Blood Cancer. 2006 Oct 15;47(5):555-9. doi: 10.1002/pbc.20586.
9
Polyethylene glycol interferon-alpha2b alone or in combination with low-dose Ara-C in patients newly diagnosed with chronic myeloid leukemia.
Haematologica. 2004 Jul;89(7):870-1.
Zotero 插件